1ST SUCCESSFUL TREATMENT OF HEMOLYTIC UREMIC SYNDROME WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) AS A CAUSAL THERAPY IN CHILDHOOD

被引：0
|
作者：
KREUZ, WD
LINDE, R
NOWAKGOTTL, U
SCHWABE, D
SEIFRIED, E
机构：
[1] UNIV FRANKFURT KLINIKUM,CTR PEDIAT,W-6000 FRANKFURT 70,GERMANY
[2] UNIV HOSP ULM,CTR INTERNAL MED,ULM,GERMANY
来源：
THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1190 / 1190
页数：1
相关论文
共 50 条
  • [31] SYSTEMIC FIBRINOLYTIC EFFECT OF PULSE-SPRAY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA)
    YUSUF, SW
    WESTBY, J
    WENHAM, PW
    HOPKINSON, BR
    MAKIN, GS
    FIBRINOLYSIS, 1994, 8 : 108 - 110
  • [32] Thrombolytic therapy of prosthetic valve thrombosis with recombinant tissue plasminogen activator (rt-PA) in infancy and childhood
    Serpi, M
    Schmidt, KG
    Kreuz, W
    Bucsenez, D
    Springer, W
    Hagl, S
    Ulmer, HE
    ZEITSCHRIFT FUR KARDIOLOGIE, 2001, 90 (03): : 191 - +
  • [33] RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR (RT-PA) - INTERACTION WITH PLASMA-PROTEINS OF THE COAGULATION AND PLASMINOGEN SYSTEMS
    BELL, WR
    TOPOL, EJ
    DANG, CV
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 287 - 287
  • [34] INTRAVENOUS AND INTRAPULMONARY RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) IN TREATMENT OF ACUTE, MASSIVE, PULMONARY-EMBOLISM - A MULTICENTER PILOT-STUDY
    VERSTRAETE, M
    MILLER, GAH
    BOUNAMEAUX, H
    CHARBONNIER, B
    COLLE, JP
    LECORF, G
    MARBET, GA
    MOMBAERTS, P
    OLSSON, CG
    BRITISH HEART JOURNAL, 1988, 59 (01): : 87 - 87
  • [35] Peripheral arterial occlusions: Local low-dose thrombolytic therapy with recombinant tissue-type plasminogen activator (rt-PA)
    Hess, H
    Mietaschk, A
    vonBilderling, P
    Neller, P
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1996, 12 (01) : 97 - 104
  • [36] PREVENTION OF CORONARY-THROMBOSIS WITH SUB-THROMBOLYTIC DOSES OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA)
    FOX, KAA
    KNABB, RM
    ROSAMOND, T
    ROBISON, AK
    SOBEL, BE
    BERGMANN, SR
    CIRCULATION, 1985, 72 (04) : 121 - 121
  • [37] ABSENCE OF SYSTEMIC FIBRINOLYSIS DURING CORONARY THROMBOLYSIS WITH RECOMBINANT HUMAN TYPE TISSUE PLASMINOGEN-ACTIVATOR (RT-PA)
    GARABEDIAN, HD
    GOLD, HK
    LEINBACH, RC
    YASUDA, T
    GROSSBARD, EB
    COLLEN, D
    CIRCULATION, 1984, 70 (04) : 331 - 331
  • [38] MECHANISMS OF ACUTE CORONARY REOCCLUSION AFTER THROMBOLYSIS WITH RECOMBINANT HUMAN TYPE TISSUE PLASMINOGEN-ACTIVATOR (RT-PA)
    GOLD, HK
    LEINBACH, RC
    YASUDA, T
    GROSSBARD, E
    COLLEN, D
    CIRCULATION, 1984, 70 (04) : 331 - 331
  • [39] BIOCHEMICAL AND BIOLOGIC PROPERTIES OF RT-PA DEL(K296-G302), A RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR DELETION MUTANT RESISTANT TO PLASMINOGEN-ACTIVATOR INHIBITOR-1
    LI, XK
    LIJNEN, HR
    NELLES, L
    VANHOEF, B
    STASSEN, JM
    COLLEN, D
    BLOOD, 1992, 79 (02) : 417 - 429
  • [40] CREATION OF THE RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR (RT-PA) IMAGE AND ITS INFLUENCE ON PRACTICE HABITS
    SHERRY, S
    MARDER, VJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (06) : 1579 - 1582
12345